Publications by authors named "Robert Milne"

Claim this Profile
A
A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma.
Laychiluh B Mekonnen, Theodosia Teo, Benjamin Noll, Muhammed H Rahaman, Jimma Lenjisa, Robert Milne

Biomed Pharmacother· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia.
Abel Tesfaye Anshabo, Laychiluh Bantie, Sarah Diab, Jimma Lenjisa, Alemwork Kebede, Robert Milne

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposomal 5-Fluorouracil Polymer Complexes Facilitate Tumor-Specific Delivery: Pharmaco-Distribution Kinetics Using Microdialysis.
Wen Wang, Paul Joyce, Kristen Bremmell, Robert Milne, Clive A Prestidge

Pharmaceutics· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to "A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer" [Gynecologic Oncology 159 (2020) 827-838].
Laychiluh Bantie, Solomon Tadesse, Jimma Likisa, Mingfeng Yu, Benjamin Noll, Robert Milne

Gynecol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents.
Abel Tesfaye Anshabo, Robert Milne, Shudong Wang, Hugo Albrecht

Front Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluation.
Mingfeng Yu, Theodosia Teo, Yuchao Yang, Manjun Li, Yi Long, Robert Milne

Eur J Med Chem· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer.
Laychiluh Bantie, Solomon Tadesse, Jimma Likisa, Mingfeng Yu, Benjamin Noll, Robert Milne

Gynecol Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-Phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine Derivatives as Potent Mnk2 Inhibitors: Design, Synthesis, SAR Analysis, and Evaluation of in vitro Anti-leukaemic Activity.
Ahmed M Abdelaziz, Sarah Diab, Saiful Islam, Sunita K C Basnet, Benjamin Noll, Robert W Milne

Med Chem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CDK9 for treatment of colorectal cancer.
Muhammed H Rahaman, Frankie Lam, Longjin Zhong, Theodosia Teo, Julian Adams, Robert W Milne

Mol Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioanalysis and Stability of Polymyxins.
Robert W Milne

Adv Exp Med Biol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulfonamide-Based Inhibitors of Biotin Protein Ligase as New Antibiotic Leads.
Kwang Jun Lee, William Tieu, Beatriz Blanco-Rodriguez, Ashleigh S Paparella, Jingxian Yu, Robert Milne

ACS Chem Biol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia.
Muhammed H Rahaman, Yingyi Yu, Longjin Zhong, Julian Adams, Frankie Lam, Robert Milne

Invest New Drugs· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing the risk of mental ill health: the importance of the early years of life.
Michael Baber, Alice Gough, Jennifer Jamieson, Robert Milne, Hong Pham

Perspect Public Health· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of CDK5 Inhibitors through Structure-Guided Approach.
Nishat Z Khair, Jimma L Lenjisa, Solomon Tadesse, Malika Kumarasiri, Sunita K C Basnet, Robert Milne

ACS Med Chem Lett· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and pharmacological characterization of a novel series of highly selective inhibitors of cyclin-dependent kinases 4 and 6 as anticancer agents.
Solomon Tadesse, Laychiluh Bantie, Khamis Tomusange, Mingfeng Yu, Saiful Islam, Robert Milne

Br J Pharmacol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselectivity in the tissue distribution of perhexiline contributes to different effects on hepatic histology and peripheral neural function in rats.
Giovanni Licari, Robert W Milne, Andrew A Somogyi, Benedetta C Sallustio

Pharmacol Res Perspect· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between total phthalate concentration and non-communicable diseases and chronic inflammation in South Australian urban dwelling men.
Peter Y Bai, Gary Wittert, Anne W Taylor, Sean A Martin, Robert W Milne

Environ Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemia.
Sarah Diab, Ahmad M Abdelaziz, Peng Li, Theodosia Teo, Sunita K C Basnet, Robert W Milne

Eur J Med Chem· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK5 in oncology: recent advances and future prospects.
Jimma Likisa Lenjisa, Solomon Tadesse, Nishat Zareen Khair, Malika Kumarasiri, Mingfeng Yu, Robert Milne

Future Med Chem· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Garlic, Gingko, and St. John's Wort Extracts on the Pharmacokinetics of Fexofenadine: A Mechanistic Study.
Jasmina Turkanovic, Michael B Ward, Jacobus P Gerber, Robert W Milne

Drug Metab Dispos· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation.
Solomon Tadesse, Mingfeng Yu, Laychiluh B Mekonnen, Frankie Lam, Saiful Islam, Robert Milne

J Med Chem· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CDK9: a promising therapeutic opportunity in prostate cancer.
Muhammed H Rahaman, Malika Kumarasiri, Laychiluh B Mekonnen, Mingfeng Yu, Sarah Diab, Robert W Milne

Endocr Relat Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling new chemical scaffolds as Mnk inhibitors.
Sarah Diab, Peng Li, Sunita K C Basnet, Jingfeng Lu, Mingfeng Yu, Robert W Milne

Future Med Chem· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells.
Peng Li, Sarah Diab, Mingfeng Yu, Julian Adams, Saiful Islam, Robert Milne

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robert Marshall Milne.
Robert Marshall Milne

BMJ· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis